High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma

Zhu, Qiaoliang; Luo, Rongkui; Gu, Jie; Hou, Yingyong; Chen, Zongwei; Xu, Fengkai; Wang, Lin; Mao, Wei; Lu, Chunlai; Ge, Di

doi:10.7150/jca.36498



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2020; 11(4):810-818. doi:10.7150/jca.36498 This issue Cite

Research Paper

High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma

Qiaoliang Zhu^1*, Rongkui Luo^2*, Jie Gu¹, Yingyong Hou², Zongwei Chen¹, Fengkai Xu¹, Lin Wang¹, Wei Mao¹, Chunlai Lu^1✉, Di Ge^1,3✉

1. Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
2. Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, P. R. China.
3. Shanghai Respiratory Research Institute, Zhongshan Hospital, Fudan University, Shanghai, P.R. China.
*Qiaoliang Zhu and Rongkui Luo contributed equally to this work.

Citation:

Zhu Q, Luo R, Gu J, Hou Y, Chen Z, Xu F, Wang L, Mao W, Lu C, Ge D. High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma. J Cancer 2020; 11(4):810-818. doi:10.7150/jca.36498. https://www.jcancer.org/v11p0810.htm

Other styles

Abstract

Background: Primary adenosquamous carcinoma (ASC) is a rare malignant tumor in the lung and its biological behavior has not yet been thoroughly described. In this study, we aimed to explore the clinical and biological role of CXCR4 in patients with resected lung ASC.

Methods: We retrospectively reviewed the clinical records of patients with histologically confirmed lung ASC who underwent surgical resection with systematic lymph node dissection. Immunohistochemical staining was performed to detect the expression of CXCR4 in tumor tissues. The correlation between CXCR4 expression and clinicopathological characteristics were evaluated. The association between CXCR4 expression and patients' prognosis was analyzed by Kaplan-Meier and Cox regression. Moreover, we performed in vitro studies including CCK8, transwell and cell apoptosis to explore the potential role of CXCR4 in lung ASC.

Results: A total of 78 patients with resected lung ASC were reviewed. Seventy (89.7%) patient tumors expressed CXCR4, with high level of CXCR4 expression observed in 45 (57.7%) cases. In vitro, CXCR4 conferred no difference in proliferative capacity but increased invasive potential, enhanced chemoresistance and inhibited apoptosis of lung ASC. Clinically, high CXCR4 expression was significantly associated with solid ASC, lymph node metastasis and advanced TNM stage. Patients with high CXCR4 expression and solid ASC had decreased disease-free survival and overall survival.Conclusions: CXCR4 was commonly expressed in lung ASC tumors. High CXCR4 expression might be a novel marker in predicting a poor prognosis in resected lung ASC and might serve as a potential therapeutic target.

Keywords: CXCR4, lung adenosquamous carcinoma, prognosis

Citation styles

APA

Zhu, Q., Luo, R., Gu, J., Hou, Y., Chen, Z., Xu, F., Wang, L., Mao, W., Lu, C., Ge, D. (2020). High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma. Journal of Cancer, 11(4), 810-818. https://doi.org/10.7150/jca.36498.

ACS

Zhu, Q.; Luo, R.; Gu, J.; Hou, Y.; Chen, Z.; Xu, F.; Wang, L.; Mao, W.; Lu, C.; Ge, D. High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma. J. Cancer 2020, 11 (4), 810-818. DOI: 10.7150/jca.36498.

NLM

CSE

Zhu Q, Luo R, Gu J, Hou Y, Chen Z, Xu F, Wang L, Mao W, Lu C, Ge D. 2020. High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma. J Cancer. 11(4):810-818.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.